About the Company
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NVIV News
InVivo’s Cordier appeals Bordeaux wine fine
Cordier was granted a fine alongside local wine merchant Maison Ginestet last month for paying “abusively low prices” to a ...
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.37%
The top performers on the NASDAQ Composite were InVivo Therapeutics Holdings Corp (NASDAQ:NVIV) which rose 136.94% to 0.53, Medavail Holdings Inc (NASDAQ:MDVL) which was up 92.40% to settle at 3.29 ...
Analysts Offer Insights on Healthcare Companies: Imunon (IMNN) and CalciMedica (CALC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Imunon (IMNN – Research Report) and ...
Loading the latest forecasts...